| Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens K Kiryluk, Y Li, F Scolari, S Sanna-Cherchi, M Choi, M Verbitsky, D Fasel, ... Nature genetics 46 (11), 1187-1196, 2014 | 644 | 2014 |
| The MEST score provides earlier risk prediction in lgA nephropathy SJ Barbour, G Espino-Hernandez, HN Reich, R Coppo, ISD Roberts, ... Kidney international 89 (1), 167-175, 2016 | 277 | 2016 |
| Corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA study V Tesar, S Troyanov, S Bellur, JC Verhave, HT Cook, J Feehally, ... Journal of the American Society of Nephrology 26 (9), 2248-2258, 2015 | 245 | 2015 |
| The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis J Xie, L Liu, N Mladkova, Y Li, H Ren, W Wang, Z Cui, L Lin, X Hu, X Yu, ... Nature communications 11 (1), 1600, 2020 | 150 | 2020 |
| Diagnostic Pathology: Kidney Diseases E-Book RB Colvin, A Chang, LD Cornell Elsevier Health Sciences, 2023 | 121 | 2023 |
| Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients A Ozkok, Y Caliskan, T Sakaci, G Erten, G Karahan, A Ozel, A Unsal, ... Clinical journal of the American Society of Nephrology 7 (6), 965-973, 2012 | 106 | 2012 |
| Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease B Yelken, Y Caliskan, N Gorgulu, I Altun, A Yilmaz, H Yazici, H Oflaz, ... Clinical nephrology 77 (4), 275, 2012 | 90 | 2012 |
| Mycophenolate mofetil in combination with steroids for treatment of C3 glomerulopathy: a case series RS Avasare, PA Canetta, AS Bomback, M Marasa, Y Caliskan, Y Ozluk, ... Clinical Journal of the American Society of Nephrology 13 (3), 406-413, 2018 | 88 | 2018 |
| Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update R Coppo, G D'Arrigo, G Tripepi, ML Russo, ISD Roberts, S Bellur, ... Nephrology Dialysis Transplantation 35 (6), 1002-1009, 2020 | 87 | 2020 |
| Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection NJ Steers, Y Li, Z Drace, JA D’Addario, C Fischman, L Liu, K Xu, YJ Na, ... New England Journal of Medicine 380 (20), 1918-1928, 2019 | 87 | 2019 |
| Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort R Coppo, D Lofaro, RR Camilla, S Bellur, D Cattran, HT Cook, ... Pediatric nephrology 32, 139-150, 2017 | 85 | 2017 |
| Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever N Alpay, A Şumnu, Y Çalışkan, H Yazıcı, A Türkmen, A Gül Rheumatology international 32, 3277-3279, 2012 | 79 | 2012 |
| Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation Y Caliskan, SK Besisik, D Sargin, T Ecder Bone marrow transplantation 38 (2), 141-147, 2006 | 73 | 2006 |
| Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience A Ozkok, TS Akpinar, F Tufan, NA Kanitez, M Uysal, M Guzel, Y Caliskan, ... Clinical and experimental nephrology 17, 345-351, 2013 | 71 | 2013 |
| Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy FP Schena, VW Anelli, J Trotta, T Di Noia, C Manno, G Tripepi, G D’Arrigo, ... Kidney international 99 (5), 1179-1188, 2021 | 69 | 2021 |
| Survey of US living kidney donation and transplantation practices in the COVID-19 era KL Lentine, LS Vest, MA Schnitzler, RB Mannon, V Kumar, MD Doshi, ... Kidney international reports 5 (11), 1894-1905, 2020 | 67 | 2020 |
| Extrapulmonary tuberculosis in immunocompetent adults AA Cagatay, Y Caliskan, S Aksoz, L Gulec, S Kucukoglu, Y Cagatay, ... Scandinavian journal of infectious diseases 36 (11-12), 799-806, 2004 | 66 | 2004 |
| The clinical significance of uric acid and complement activation in the progression of IgA nephropathy Y Caliskan, Y Ozluk, D Celik, N Oztop, A Aksoy, AS Ucar, H Yazici, ... Kidney and Blood Pressure Research 41 (2), 148-157, 2016 | 64 | 2016 |
| Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years S Kalayoglu-Besisik, MN Yenerel, Y Caliskan, S Ozturk, F Besisik, ... Transplantation proceedings 37 (5), 2285-2289, 2005 | 59 | 2005 |
| Effect of pre-transplant dialysis modality on kidney transplantation outcome Y Caliskan, H Yazici, N Gorgulu, B Yelken, T Emre, A Turkmen, A Yildiz, ... Peritoneal dialysis international 29 (2_suppl), 117-122, 2009 | 57 | 2009 |
AYDIN TÜRKMENIstanbul School of Medicine在 istanbul.edu.tr 的电子邮件经过验证
